# Insights from ESMO Asia Congress 2024

**Authors:** Thittayil Suresh Apoorv

PMC · DOI: 10.1016/j.lansea.2025.100554 · The Lancet Regional Health - Southeast Asia · 2025-02-21

## Full-text entities

- **Diseases:** biliary tract cancers (MESH:D001661), muscle-invasive (MESH:D000093284), non-small cell lung cancer (MESH:D002289), pancreatic cancer (MESH:D010190), Breast Cancer (MESH:D001943), bladder cancer (MESH:D001749), cancer (MESH:D009369), epithelial ovarian cancer (MESH:D000077216), deaths (MESH:D003643), cervical cancer (MESH:D002583)
- **Chemicals:** CheckMate 274 (-), gemcitabine (MESH:D000093542), cisplatin (MESH:D002945), durvalumab (MESH:C000613593), PAP (MESH:D010724), nivolumab (MESH:D000077594)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11904512/full.md

---
Source: https://tomesphere.com/paper/PMC11904512